|
1
|
Mack B and Gires O: CD44s and CD44v6
expression in head and neck epithelia. PLoS One. 3:e33602008.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yoshida Y, Sato K, Kin M, Suzuki T, Bessho
H, Tanaka Y and Katakura: Relative factors of late cervical lymph
node metastasis in patients with stage I or II oral squamous cell
carcinoma. J oral Maxillo Surg Med Pathol. 28:156–161. 2016.
View Article : Google Scholar
|
|
3
|
Okudela K, Woo T, Mitsui H, Tajiri M,
Masuda M and Ohashi K: Expression of the potential cancer stem cell
markers, CD133, CD44, ALDH1 and β-catenin, in primary lung
adenocarcinoma-their prognostic significance. Pathol Int.
62:792–801. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hirata K, Suzuki H, Imaeda H, Matsuzaki J,
Tsugawa H, Nagano O, Asakura K, Saya H and Hibi T: CD44 variant 9
expression in primary early gastric cancer as a predictive marker
for recurrence. Br J Cancer. 109:379–386. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kimura Y, Goi T, Nakazawa T, Hirono Y,
Katayama K, Urano T and Yamaguchi A: CD44variant exon 9 plays an
important role in colon cancer initiating cells. Oncotarget.
4:785–791. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Go SI, Ko GH, Lee WS, Kim RB, Lee JH,
Jeong SH, Lee YJ, Hong SC and Ha WS: CD44 Variant 9 serves as a
poor prognostic marker in early gastric cancer, but not in advanced
gastric cancer. Cancer Res Treat. 48:142–152. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Robey RW, To KK, Polgar O, Dohse M, Fetsch
P, Dean M and Bates SE: ABCG2: A perspective. Adv Drug Deliv Rev.
61:3–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bhagwandin VJ, Bishop JM, Wright WE and
Shay JW: The Metastatic potential and chemoresistance of human
pancreatic cancer stem cells. PLoS One. 11:e01488072016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tang Y, Hou J, Li G, Song Z, Li X, Yang C,
Liu W, Hu Y and Xu Y: ABCG2 regulates the pattern of self-renewing
divisions in cisplatin-resistant non-small cell lung cancer cell
lines. Oncol Rep. 32:2168–2174. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hoe SL, Tan LP, Jamal J, Peh SC, Ng CC,
Zhang WC, Ahmad M and Khoo AS: Evaluation of stem-like side
population cells in a recurrent nasopharyngeal carcinoma cell line.
Cancer Cell Int. 14:1012014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sano A, Kato H, Sakurai S, Sakai M, Tanaka
N, Inose T, Saito K, Sohda M, Nakajima M, Nakajima T and Kuwano H:
CD24 expression is a novel prognostic factor in esophageal squamous
cell carcinoma. Ann Surg Oncol. 16:506–514. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Oliveira LR, Oliveira-Costa JP, Araujo IM,
Soave DF, Zanetti JS, Soares FA, Zucoloto S and Ribeiro-Silva A:
Cancer stem cell immunophenotypes in oral squamous cell carcinoma.
J Oral Pathol Med. 40:135–142. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kristiansen G, Winzer KJ, Mayordomo E,
Bellach J, Schlüns K, Denkert C, Dahl E, Pilarsky C, Altevogt P,
Guski H and Dietel M: CD24 expression is a new prognostic marker in
breast cancer. Clin Cancer Res. 9:4906–4913. 2003.PubMed/NCBI
|
|
14
|
Karahan N, Güney M, Oral B, Kapucuoglu N
and Mungan T: CD24 expression is a poor prognostic marker in
endometrial carcinoma. Eur J Gynaecol Oncol. 27:500–504.
2006.PubMed/NCBI
|
|
15
|
Sagiv E, Starr A, Rozovski U, Khosravi R,
Altevogt P, Wang T and Arber N: Targeting CD24 for treatment of
colorectal and pancreatic cancer by monoclonal antibodies or small
interfering RNA. Cancer Res. 68:2803–2812. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Choy B, Bandla S, Xia Y, Tan D, Pennathur
A, Luketich JD, Godfrey TE, Peters JH, Sun J and Zhou Z:
Clinicopathologic characteristics of high expression of Bmi-1 in
esophageal adenocarcinoma and squamous cell carcinoma. BMC
Gastroenterol. 12:1462012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Feng JQ, Mi JG, Wu L, Ma LW, Shi LJ, Yang
X, Liu W, Zhang CP and Zhou ZT: Expression of podoplanin and ABCG2
in oral erythroplakia correlate with oral cancer development. Oral
Oncol. 48:848–852. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Allegra E, Caltabiano R, Amorosi A,
Vasquez E, Garozzo A and Puzzo L: Expression of BMI1 and p16 in
laryngeal squamous cell carcinoma. Head Neck. 35:847–851. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Goossens-Beumer IJ, Zeestraten EC, Benard
A, Christen T, Reimers MS, Keijzer R, Sier CF, Liefers GJ, Morreau
H, Putter H, et al: Clinical prognostic value of combined analysis
of Aldh1, Survivin and EpCAM expression in colorectal cancer. Br J
Cancer. 110:2935–2944. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kahlert C, Bergmann F, Beck J, Welsch T,
Mogler C, Herpel E, Dutta S, Niemietz T, Koch M and Weitz J: Low
expression of aldehyde dehydrogenase 1A1 (ALDH1A1) is a prognostic
marker for poor survival in pancreatic cancer. BMC Cancer.
11:2752011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Luo WR, Gao F, Li SY and Yao KT: Tumour
budding and the expression of cancer stem cell marker aldehyde
dehydrogenase 1 in nasopharyngeal carcinoma. Histopathology.
61:1072–1081. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Patel M, Lu L, Zander DS, Sreerama L, Coco
D and Moreb JS: ALDH1A1 and ALDH3A1 expression in lung cancers:
Correlation with histologic type and potential precursors. Lung
Cancer. 59:340–349. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jakobsson PA, Eneroth CM, Killander D,
Moberger G and Mårtensson B: Histologic classification and grading
of malignancy in carcinoma of the larynx. Acta Radiol Ther Phys
Biol. 12:1–8. 1973. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Willén R, Nathanson A, Moberger G and
Anneroth G: Squamous cell carcinoma of the gingiva. Histological
classification and grading of malignancy. Acta Otolaryngol.
79:146–154. 1975. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yamamoto E, Miyakawa A and Kohama G: Mode
of invasion and lymph node metastasis in squamous cell carcinoma of
the oral cavity. Head Neck Surg. 6:938–947. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Prince ME, Sivanandan R, Kaczorowski A,
Wolf GT, Kaplan MJ, Dalerba P, Weissman IL, Clarke MF and Ailles
LE: Identification of a subpopulation of cells with cancer stem
cell properties in head and neck squamous cell carcinoma. Proc Natl
Acad Sci USA. 104:973–978. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sato S, Miyauchi M, Takekoshi T, Zhao M,
Kudo Y, Ogawa I, Kitagawa S, Fujita M and Takata T: Reduced
expression of CD44 variant 9 is related to lymph node metastasis
and poor survival in squamous cell carcinoma of tongue. Oral Oncol.
36:545–549. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kokko LL, Hurme S, Maula SM, Alanen K,
Grénman R, Kinnunen I and Ventelä S: Significance of site-specific
prognosis of cancer stem cell marker CD44 in head and neck
squamous-cell carcinoma. Oral Oncol. 47:510–516. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Huang CF, Xu XR, Wu TF, Sun ZJ and Zhang
WF: Correlation of ALDH1, CD44, OCT4 and SOX2 in tongue squamous
cell carcinoma and their association with disease progression and
prognosis. J Oral Pathol Med. 43:492–498. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mack B and Gires O: CD44s and CD44v6
expression in head and neck epithelia. PLoS One. 3:e33602008.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Clay MR, Tabor M, Owen JH, Carey TE,
Bradford CR, Wolf GT, Wicha MS and Prince ME: Single-marker
identification of head and neck squamous cell carcinoma cancer stem
cells with aldehyde dehydrogenase. Head Neck. 32:1195–1201. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu W, Feng JQ, Shen XM, Wang HY, Liu Y
and Zhou ZT: Two stem cell markers, ATP-binding cassette, G2
subfamily (ABCG2) and BMI-1, predict the transformation of oral
leukoplakia to cancer: A long-term follow-up study. Cancer.
118:1693–1700. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Shi P, Liu W, Zhou ZT, He QB and Jiang WW:
Podoplanin and ABCG2: Malignant transformation risk markers for
oral lichen planus. Cancer Epidemiol Biomarkers Prev. 19:844–849.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Choi D, Lee HW, Hur KY, Kim JJ, Park GS,
Jang SH, Song YS, Jang KS and Paik SS: Cancer stem cell markers
CD133 and CD24 correlate with invasiveness and differentiation in
colorectal adenocarcinoma. World J Gastroenterol. 15:2258–2264.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Tanaka T, Terai Y, Kogata Y, Ashihara K,
Maeda K, Fujiwara S, Yoo S, Tanaka Y, Tsunetoh S, Sasaki H, et al:
CD24 expression as a marker for predicting clinical outcome and
invasive activity in uterine cervical cancer. Oncol Rep.
34:2282–2228. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li X, Kong X, Huo Q, Guo H, Yan S, Yuan C,
Moran MS, Shao C and Yang Q: Metadherin enhances the invasiveness
of breast cancer cells by inducing epithelial to mesenchymal
transition. Cancer Sci. 102:1151–1157. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wakamatsu Y, Sakamoto N, Oo HZ, Naito Y,
Uraoka N, Anami K, Sentani K, Oue N and Yasui W: Expression of
cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and
lymph node metastasis of gastric cancer. Pathol Int. 62:112–119.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chang B, Liu G, Xue F, Rosen DG, Xiao L,
Wang X and Liu J: ALDH1 expression correlates with favorable
prognosis in ovarian cancers. Mod Pathol. 22:817–823. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Dimou A, Neumeister V, Agarwal S,
Anagnostou V, Syrigos K and Rimm DL: Measurement of aldehyde
dehydrogenase 1 expression defines a group with better prognosis in
patients with non-small cell lung cancer. Am J Pathol.
181:1436–1442. 2012. View Article : Google Scholar : PubMed/NCBI
|
